Infectious Diseases – Assay Design

The development of a new assay starts with a need – the need for quick, reliable answers. ATCC is here to help.




Optimizing experimental conditions can be challenging during the design phase of assay development, including sourcing organisms or nucleic acids with known traits or relevant genes. For this reason, ATCC has expanded its portfolio to include:


  • Cultures grouped by agent or source of isolation
  • Cultures tested for clinically-relevant phenotypic characteristics
  • Fully-sequenced strains
  • Native nucleic acids
  • Synthetic nucleic acids containing clinically-relevant gene sequences

Moreover, ATCC cultures and nucleic acids are produced under ISO 9001:2008 certified and ISO/IEC 17025:2005 accredited processes, so you can trust your results and reproduce your data – every time.

 

Find the resources you need using the links provided below. Or, contact the ATCC Sales Team.

ATCC Genuine Cultures®

ATCC offers an extensive array of cells and microorganisms to promote research leading to novel methods of detecting, minimizing, and treating infectious diseases.

 

Enteric

Respiratory

Vector-borne

Sexually Transmitted

ATCC® Genuine Nucleics

ATCC® Genuine Nucleics represents the largest and most diverse array of native, synthetic, and certified reference materials for use in molecular-based assays, quality control, and assay development.

 

Learn more

Fully Sequenced Strains

ATCC provides all the cultures you need to perform complex analysis of sequenced genomes, including fungi, yeasts, bacteria, and protozoa.

 

Explore cultures